Linked Life Data

15136219

Source:http://linkedlifedata.com/resource/pubmed/id/15136219

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2004-5-11
pubmed:abstractText
Detection of minimal residual disease (MRD) has helped to improve the treatment of patients with leukemia. At present MRD testing in patients with multiple myeloma (MM) is not applied as a standard diagnostic or prognostic method.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1592-8721
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
557-66
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma.
pubmed:affiliation
Dept. of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, Germany. fenk@med.uni-duesseldorf.de
pubmed:publicationType
Journal Article